JP2006513154A5 - - Google Patents

Download PDF

Info

Publication number
JP2006513154A5
JP2006513154A5 JP2004544675A JP2004544675A JP2006513154A5 JP 2006513154 A5 JP2006513154 A5 JP 2006513154A5 JP 2004544675 A JP2004544675 A JP 2004544675A JP 2004544675 A JP2004544675 A JP 2004544675A JP 2006513154 A5 JP2006513154 A5 JP 2006513154A5
Authority
JP
Japan
Prior art keywords
group
alkyl
cycloalkyl
aryl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004544675A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006513154A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2003/000855 external-priority patent/WO2004035037A2/en
Publication of JP2006513154A publication Critical patent/JP2006513154A/ja
Publication of JP2006513154A5 publication Critical patent/JP2006513154A5/ja
Pending legal-status Critical Current

Links

JP2004544675A 2002-10-21 2003-10-21 カリウムチャネルおよび/または皮質ニューロン活性モジュレーターとしての、n−フェニルアントラニル酸および2−ベンズイミダゾロンの誘導体 Pending JP2006513154A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41952502P 2002-10-21 2002-10-21
PCT/IL2003/000855 WO2004035037A2 (en) 2002-10-21 2003-10-21 Derivatives of n-phenylanthranilic acid and 2-benzimidazolon as potassium channel and/or cortical neuron activity modulators

Publications (2)

Publication Number Publication Date
JP2006513154A JP2006513154A (ja) 2006-04-20
JP2006513154A5 true JP2006513154A5 (cg-RX-API-DMAC7.html) 2006-12-07

Family

ID=32108098

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004544675A Pending JP2006513154A (ja) 2002-10-21 2003-10-21 カリウムチャネルおよび/または皮質ニューロン活性モジュレーターとしての、n−フェニルアントラニル酸および2−ベンズイミダゾロンの誘導体

Country Status (6)

Country Link
EP (1) EP1553932A2 (cg-RX-API-DMAC7.html)
JP (1) JP2006513154A (cg-RX-API-DMAC7.html)
KR (1) KR20050074493A (cg-RX-API-DMAC7.html)
AU (1) AU2003272068A1 (cg-RX-API-DMAC7.html)
CA (1) CA2503075A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004035037A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632866B2 (en) 2002-10-21 2009-12-15 Ramot At Tel Aviv University Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators
WO2009037707A2 (en) 2007-09-20 2009-03-26 Ramot At Tel Aviv University Ltd. N-phenyl anthranilic acid derivatives and uses thereof
GB0723794D0 (en) 2007-12-05 2008-01-16 Lectus Therapeutics Ltd Potassium ion channel modulators and uses thereof
GB0813403D0 (en) * 2008-07-22 2008-08-27 Lectus Therapeutics Ltd Potassium ion channel modulators & uses thereof
JP7448472B2 (ja) * 2017-10-09 2024-03-12 ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド カリウムイオンチャネル及びtrpv1チャネルのモジュレーター、並びにその使用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5032189A (cg-RX-API-DMAC7.html) * 1973-07-20 1975-03-28
JPS5095285A (cg-RX-API-DMAC7.html) * 1973-12-26 1975-07-29
JPH05132431A (ja) * 1990-03-28 1993-05-28 Nippon Oil & Fats Co Ltd 高分子化薬剤およびその製造法
US5565483A (en) * 1995-06-07 1996-10-15 Bristol-Myers Squibb Company 3-substituted oxindole derivatives as potassium channel modulators
ITMI962356A1 (it) * 1996-11-13 1998-05-13 Uni Degli Studi Di Brescia D I Uso di composti derivati da molecole ad attivita' antinfiammatoria di tipo non steroideo per la prevenzione e il trattamento di
ATE344791T1 (de) * 1997-07-01 2006-11-15 Warner Lambert Co 2-(4-brom or 4-iod phenylamino)benzoesäurederivate und ihre anwendung als mek-inhibitoren
US6291442B1 (en) * 1998-02-03 2001-09-18 The General Hospital Corporation Pharmacological modulators of voltage-gated potassium ion channels
EP1144387A1 (en) * 1998-12-04 2001-10-17 Neurosearch A/S New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
US6472165B1 (en) * 1999-08-03 2002-10-29 Arzneimittelwerk Dresden Gmbh Modulatory binding site in potassium channels for screening and finding new active ingredients
US6713454B1 (en) * 1999-09-13 2004-03-30 Nobex Corporation Prodrugs of etoposide and etoposide analogs
US6413507B1 (en) * 1999-12-23 2002-07-02 Shearwater Corporation Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
US6429223B1 (en) * 2000-06-23 2002-08-06 Medinox, Inc. Modified forms of pharmacologically active agents and uses therefor
US6348486B1 (en) * 2000-10-17 2002-02-19 American Home Products Corporation Methods for modulating bladder function
GB0026838D0 (en) * 2000-11-02 2000-12-20 Glaxo Group Ltd Treatment method
US6593349B2 (en) * 2001-03-19 2003-07-15 Icagen, Inc. Bisarylamines as potassium channel openers
WO2009037707A2 (en) * 2007-09-20 2009-03-26 Ramot At Tel Aviv University Ltd. N-phenyl anthranilic acid derivatives and uses thereof

Similar Documents

Publication Publication Date Title
CN100369894C (zh) 氧化氮合酶抑制剂磷酸盐
CN1043531C (zh) 嘧啶衍生物及其制备方法和用途
AU623733B2 (en) Benzofused-n-containing heterocyle derivatives
WO2005092895A3 (en) Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
RU2004111979A (ru) Производные 1н-имидазола, обладающие св1-агонистической, частичной св1-агонистической или св1-антагонистической активностью
RU2004107131A (ru) Новые производные 4,5-дигидро-1h-пиразола, имеющие cb1- антагонистическую активность
JP2006504710A5 (cg-RX-API-DMAC7.html)
RU2007105350A (ru) 3-(гетероарилокси)-2-алкил-1-азабициклоалкильные производные, как лиганды альфа-7-nachr (никотиновых ацетилхолиновых рецепторов), предназначенные для лечения заболеваний центральной нервной системы
RU2005106846A (ru) Производные бензотиазола, характеризующиеся агонистической активностью к бета-2-адренорецепторам
ATE478872T1 (de) Pyrazoloä4,3-düpyrimidine, verfahren zu ihrer herstellung und therapeutische anwendung
MA32088B1 (fr) Dérivés bicycliques de carboxamides azabicycliques, leur préparation et leur application en thérapeutique
JP2006502119A5 (cg-RX-API-DMAC7.html)
EP1619192A3 (en) Aryl fused azapolycyclic compounds
MX2010006182A (es) Derivados de isoxazolo-piridazina.
EP2423207A3 (en) 2-(cyclic amino)-pyrimidone derivatives as TPK1 inhibitors
KR960700268A (ko) 티아졸리딘 유도체, 이의 제조 방법 및 이를 함유한 약제(thiazolidine derivatives, prepartion thereof and drugs containing same)
EP2412707A3 (en) 3-[2-(3-Amino-2-oxo-2H-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
CA2464358A1 (en) Alkyl ether derivatives or their salts
JP2019527724A5 (cg-RX-API-DMAC7.html)
CA2336412A1 (en) Medicament for treatment of diabetes
EP1569907A1 (en) Nicotinamide-based kinase inhibitors
CN1072213C (zh) 胍衍生物的制备方法及其中间体
JP2005519989A5 (cg-RX-API-DMAC7.html)
CA2440014A1 (en) Beta-carboline derivatives and its pharmaceutical use against depression and anxiety
JP2002530378A5 (cg-RX-API-DMAC7.html)